Skip to main content
Caplight Logo









Abridge Inc

Abridge Inc

Private
Pittsburgh, PennsylvaniaHealthcare & Life Scienceshttps://www.abridge.com/

Last Round

Series E

Jun 24, 2025

Est. Valuation

$5.3B

Total Funding Raised

$747.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Abridge Inc is a healthcare technology company that provides an AI-powered platform for clinical documentation by transcribing and summarizing patient-clinician conversations.

Sector

Healthcare & Life Sciences

Verticals

NLP & Conversational AI, EHR & EMR, Medical AI, Clinical Trials, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

ambient clinical documentationAI scribeclinical documentationambient AIelectronic health recordEHRclinical trial recruitmentworkflow automationmedical AIhealthcare SaaSclinical conversation AIpayer workflowphysician burnoutAI scribe software

Price History

Caplight MarketPrice™ estimate for Abridge Inc, published with a 90-day delay.

Delayed data

Caplight MarketPrice™

$180.87

per share, as of June 2026

-23.9%

8-month change

The most recent months of MarketPrice™ are available to Caplight clients.

Caplight MarketPrice™ is an estimate of private secondary market pricing, shown here on a delayed basis for illustrative purposes only. It may be incomplete, is subject to change, and may not be relied upon for any purpose or considered investment advice.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abridge Inc Comparables

Compare Abridge Inc with similar companies based on industry and business-model similarity.

Abridge Inc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Commure
90%
Suki
88%
Ambience Healthcare
88%

Abridge Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EJun 24, 2025
Series DFeb 17, 2025
Series CFeb 23, 2024
Series BOct 26, 2023
Series A ExtensionAug 11, 2022
Seed
Oct 6, 2020

Secondary Market Activity

Bids, offers, and trades by month

Data table
OperationDatePriceSizeShare ClassStructure
TRADE

Key People

Founding team and executive leadership

Holly Dei Wesselhöft

Executive Operations, Office of the CEO

Executive Team

Shiv Rao

CEO, Co-Founder

Founding Team

Zachary Lipton

Chief Technology Officer, Chief Scientific Officer

Executive Team

Julia Chou

Chief Operating Officer

Executive Team

Abridge Inc Investors

Notable investors and investment history

Abridge Inc investors
InvestorRounds
Andreessen HorowitzSeries E
SV AngelSeries D
California Health Care FoundationSeries D
Aetna VenturesSeries B
Union Square VenturesSeries C, Series A Extension, Series B, Seed
Kaiser Permanente VenturesSeries B, Series C
Khosla VenturesSeries E

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 24, 2026

    Grew 20% QoQ, from 532 to 637 employees.

  • Jun 21, 2026

    Added Inova Health System as a customer.

Recent news

Latest coverage and updates

  • is_developingSep 21, 2026

    Abridge is developing clinical model.

  • has_revenueAug 25, 2026

    Abridge had revenue of $117M on Jan 1st '25.

  • has_valuationAug 25, 2026

    Abridge had valuation of $850M on Feb 1st '24.

  • has_valuationAug 25, 2026

    Abridge had valuation of $2.75B on Feb 1st '25.

  • has_revenueAug 25, 2026

    Abridge had revenue of $100M on Jul 1st '25.

Abridge Inc Filings

Explore SEC and related filing metadata, where available.

Abridge Inc filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Abridge Inc's valuation, stock price, and market status.

Is Abridge Inc a public or private company?

Abridge Inc is a private company.

What is the current stock price of Abridge Inc?

Abridge Inc is a private company with no public stock price. Caplight tracks Abridge Inc's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Abridge Inc worth (valuation)?

Abridge Inc's valuation is estimated at $5.3B based on funding round data.

Can I buy Abridge Inc stock?

Abridge Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Abridge Inc's last funding round?

Abridge Inc's most recent funding round was Series E on June 24, 2025.

Who are the main investors in Abridge Inc?

Key investors in Abridge Inc include Andreessen Horowitz, Union Square Ventures, UPMC, Spark Capital, Institutional Venture Partners (IVP).

Will Abridge Inc IPO soon?

No public IPO plans have been announced for Abridge Inc.

How can I track Abridge Inc secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Abridge Inc's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Employee Range498
Year Founded2018
Last FundingJun 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?